Answers are grounded in this paper and cite their sources.
Two hundred asthmatic patients were selected for the study of their immunoglobulin level, out of these one hundred eighty three patients were receiving disodium cromoglycate (DSCG) as an anti-allergic drug. We found DSCG inhibit IgE production in the patients of bronchial asthma while the production of IgM, IgG and IgA was not affected. Our study proves that disodium Cromo glycate is very useful in lowering down the concentration of IgE level in asthmatic patients.
No takes yet. Share an insight, caveat, or question.
Aashi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: